IP Library Granted Patent US 12,594,361
Granted Patent B2
US 12,594,361 · App. 18/462,346 · Granted Apr 7, 2026

Hernia repair, breast reconstruction and sling devices containing poly(butylene succinate) and copolymers thereof

Inventors: Simon F. Williams (Cambridge, MA); Said Rizk (Windham, NH); David P. Martin (Arlington, MA); Amit Ganatra (Attleboro, MA)
Assignee: Tepha, Inc.
A61L27/18A61F2/0045A61F2/0063A61F2/12A61L17/06A61L17/105A61L17/12A61L27/54A61L27/56A61L27/58A61L31/06A61L31/146A61L31/148C08L65/00C08L67/00D02G3/045D02G3/448D02G3/449A61F2002/0068A61F2220/0016A61F2240/002A61F2250/0067A61L17/005A61L27/48A61L31/16A61L2300/404A61L2300/416A61L2430/04A61L2430/34A61L2430/38D10B2331/04D10B2401/063D10B2509/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,594,361
App. No.
18/462,346
Granted
Apr 7, 2026
Kind
B2
Abstract

Resorbable implants comprising poly(butylene succinate) and copolymers thereof have been developed. The implants implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing, and the fibers may be oriented. Coverings and receptacles made from forms of poly(butylene succinate) and copolymers thereof have also been developed for use with cardiac rhythm management devices and other implantable devices. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings and receptacles are made from meshes, webs, lattices, non-wovens, films, fibers, and foams, and contain antibiotics such as rifampin and minocycline.

Claims (28)

1 . A resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh, wherein the resorbable hernia repair mesh, resorbable sling device, or resorbable breast reconstruction mesh comprises monofilament fibers, multifilament fibers, or a combination thereof, formed from an oriented polymer comprising poly(butylene succinate) and/or copolymers thereof,

wherein:

(a) the burst strength of the resorbable hernia repair mesh is between 1 kgf and 100 kgf;

(b) the burst strength of the resorbable sling device is between 1 kgf and 100 kgf;

(c) the burst strength of the resorbable breast reconstruction mesh is between 0.5 kgf and 50 kgf; and

(d) the polymer excludes urethane bonds and is not prepared with a diisocyanate.

2 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 1 , wherein the monofilament and/or multifilament fibers have been oriented by drawing to produce a total orientation ratio over 6.

3 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 2 , wherein the monofilament and/or multifilament fibers have been oriented by drawing to produce a total orientation ratio over 8.

4 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 1 , wherein the polymer is free of any metal, other than silicon, titanium and zinc, in an amount detectable by particle-induced X-ray emission (PIXE) analysis.

5 . A resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh, wherein the resorbable hernia repair mesh, resorbable sling device, or resorbable breast reconstruction mesh comprises monofilament fibers, multifilament fibers, or a combination thereof, formed from a polymer comprising poly(butylene succinate) and/or copolymers thereof,

wherein the cores of the monofilament fibers and/or the cores of the multifilament fibers comprise the poly(butylene succinate) and/or copolymers thereof, and

wherein:

(a) the burst strength of the resorbable hernia repair mesh is between 1 kgf and 100 kgf;

(b) the burst strength of the resorbable sling device is between 1 kgf and 100 kgf;

(c) the burst strength of the resorbable breast reconstruction mesh is between 0.5 kgf and 50 kgf; and

(d) the polymer excludes urethane bonds and is not prepared with a diisocyanate.

6 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 1 , wherein the Young's modulus of the monofilament fiber is at least 600 MPa.

7 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 1 , wherein the oriented polymer comprises one or more of the following: a branching agent, a cross-linking agent, a chain extender agent, a reactive blending agent, and combinations thereof.

8 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 7 , wherein the branching agent, the cross-linking agent, or the chain extender agent is selected from one or more of the following: malic acid, maleic acid, fumaric acid, trimethylol propane, trimesic acid, citric acid, glycerol propoxylate, and tartaric acid.

9 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 1 , wherein the resorbable hernia repair mesh, the resorbable sling device or the resorbable breast reconstruction mesh has a suture pullout strength of greater than or equal to 10 N.

10 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 1 , wherein the oriented polymer has an endotoxin content of less than 2.5 EU/g.

11 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 5 , wherein the monofilament and/or multifilament fibers have been oriented by drawing to produce a total orientation ratio over 6.

12 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 11 , wherein the monofilament and/or multifilament fibers have been oriented by drawing to produce a total orientation ratio over 8.

13 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 5 , wherein the polymer is free of any metal, other than silicon, titanium and zinc, in an amount detectable by PIXE analysis.

14 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 5 , wherein the Young's modulus of the monofilament fiber is at least 600 MPa.

15 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 5 , wherein the polymer comprises one or more of the following: a branching agent, a cross-linking agent, a chain extender agent, a reactive blending agent, and combinations thereof.

16 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 15 , wherein the branching agent, the cross-linking agent, or the chain extender agent is selected from one or more of the following: malic acid, maleic acid, fumaric acid, trimethylol propane, trimesic acid, citric acid, glycerol propoxylate, and tartaric acid.

17 . The resorbable hernia repair mesh, resorbable sling device or resorbable breast reconstruction mesh of claim 5 , wherein the resorbable hernia repair mesh, the resorbable sling device or the resorbable breast reconstruction mesh has a suture pullout strength of greater than or equal to 10 N.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2023
From: WILLIAMS, SIMON F.; RIZK, SAID; MARTIN, DAVID P.
To: TEPHA, INC.
Reel/Frame 065440/0667 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2023
From: GANATRA, AMIT
To: TEPHA, INC.
Reel/Frame 065440/0697 →
Continuity (4)
Continuation 16290739 · Mar 1, 2019
Provisional Application 62733384 · Sep 19, 2018
Provisional Application 62636930 · Mar 1, 2018
Related Publication 20230414829A1 · Dec 28, 2023
References Cited (90)
US 5349028A · Tetuya et al. · 1994 [cited by applicant]
US 7317069B2 · Takayuki et al. · 2008 [cited by applicant]
US 7700500B2 · Jordan et al. · 2010 [cited by applicant]
US 7972692B2 · Chakravarty et al. · 2011 [cited by applicant]
US 8680229B2 · Maeda et al. · 2014 [cited by applicant]
US 8747974B2 · Nakano et al. · 2014 [cited by applicant]
US 9480780B2 · Martin et al. · 2016 [cited by applicant]
US 10058639B2 · Zhang et al. · 2018 [cited by applicant]
US 10595983B1 · Ferguson et al. · 2020 [cited by applicant]
US 10689498B2 · Connelly et al. · 2020 [cited by applicant]
US 10994057B2 · Williams et al. · 2021 [cited by applicant]
US 11292885B1 · Connelly et al. · 2022 [cited by applicant]
US 11786632B2 · Williams et al. · 2023 [cited by applicant]
US 11844879B2 · Williams et al. · 2023 [cited by applicant]
US 11878087B2 · Williams et al. · 2024 [cited by applicant]
US 11896734B2 · Williams et al. · 2024 [cited by applicant]
US 20050027098A1 · Hayes · 2005 [cited by applicant]
US 20070026043A1 · Guan et al. · 2007 [cited by applicant]
US 20080147165A1 · Hossainy et al. · 2008 [cited by applicant]
US 20080287024A1 · Chakravarty et al. · 2008 [cited by applicant]
US 20090171037A1 · Aoshima et al. · 2009 [cited by applicant]
US 20100249332A1 · Ferguson et al. · 2010 [cited by applicant]
US 20100249361A1 · Wang et al. · 2010 [cited by applicant]
US 20110293685A1 · Kuo et al. · 2011 [cited by applicant]
US 20120221118A1 · Bartee et al. · 2012 [cited by applicant]
US 20120283826A1 · Moses · 2012 [cited by applicant]
US 20120315225A1 · Porbeni et al. · 2012 [cited by applicant]
US 20130090521A1 · Lau et al. · 2013 [cited by applicant]
US 20130267972A1 · Peniston et al. · 2013 [cited by applicant]
US 20140276995A1 · Lau et al. · 2014 [cited by applicant]
US 20150126615A1 · Martin et al. · 2015 [cited by applicant]
US 20150148514A1 · Makal · 2015 [cited by applicant]
US 20150258238A1 · Ferguson et al. · 2015 [cited by applicant]
US 20160166727A1 · Ganatra et al. · 2016 [cited by applicant]
US 20170239383A1 · Koyfman et al. · 2017 [cited by applicant]
US 20190269815A1 · Williams et al. · 2019 [cited by applicant]
US 20190269816A1 · Williams et al. · 2019 [cited by applicant]
US 20190269817A1 · Williams et al. · 2019 [cited by applicant]
US 20190269822A1 · Williams et al. · 2019 [cited by applicant]
US 20200390933A1 · Williams et al. · 2020 [cited by applicant]
US 20200390944A1 · Williams et al. · 2020 [cited by applicant]
US 20210046212A1 · Williams et al. · 2021 [cited by applicant]
US 20210047484A1 · Williams et al. · 2021 [cited by applicant]
US 20210244860A1 · Williams et al. · 2021 [cited by applicant]
US 20220202988A1 · Williams et al. · 2022 [cited by applicant]
US 20230414829A1 · Williams et al. · 2023 [cited by applicant]
CN 105903073A · 2016 [cited by applicant]
CN 106957434A · 2017 [cited by applicant]
IN 201641013616A · 2016 [cited by applicant]
JP H0711517A · 1995 [cited by applicant]
JP H07173715A · 1995 [cited by applicant]
JP H08134719A · 1996 [cited by applicant]
JP H08158154A · 1996 [cited by applicant]
JP H08317968A · 1996 [cited by applicant]
JP H0941220A · 1997 [cited by applicant]
JP H09195122A · 1997 [cited by applicant]
JP H1099424A · 1998 [cited by applicant]
JP 2000102599A · 2000 [cited by applicant]
JP 2000282357A · 2000 [cited by applicant]
JP 2004323990A · 2004 [cited by applicant]
JP 200792048A · 2007 [cited by applicant]
JP 2007215803A · 2007 [cited by applicant]
JP 2007222277A · 2007 [cited by applicant]
JP 200895212A · 2008 [cited by applicant]
JP 2013042914A · 2013 [cited by applicant]
JP 2016124935A · 2016 [cited by applicant]
WO WO2006115226A1 · 2006 [cited by applicant]
WO WO2014173055A1 · 2014 [cited by applicant]
WO WO2016192632A1 · 2016 [cited by applicant]
International Search Report and Written Opinion mailed Jul. 3, 2019 for International Application No. PCT/US2019/020348. [cited by applicant]
International Search Report and Written Opinion mailed Dec. 10, 2020 for International Application No. PCT/US2020/048773. [cited by applicant]
International Preliminary Report on Patentability mailed Nov. 12, 2021 for International Application No. PCT/US2020/048773. [cited by applicant]
[No Author Listed] Definition of “mastopexy”. Accessed online on Feb. 10, 2021 at https://www.plasticsurgery.org. (Year: 2021). [cited by applicant]
[No Author Listed] Definition of “orient”. Accessed online on Feb. 10, 2021 at https://www.collinsdictionary.com. (Year: 2021). [cited by applicant]
[No Author Listed] Definition of “Rhytidectomy”. Accessed online on Feb. 10, 2021 at https://www.plasticsurgery.org. (Year: 2021). [cited by applicant]
[No Author Listed] Food and Drug Administration's Guidance for Industry Pyrogen and Endotoxins Testing: Questions and Answers (Jun. 2012) accessed online on Feb. 11, 2021 at https://www.fda.gov. [cited by applicant]
[No Author Listed] Polybutylene Succinate. Polymer properties database. Accessed online on Feb. 12, 2021 at https://polymerdatabase.com (Year: 2021). [cited by applicant]
Costa-Pinto et al., Chitosan-poly (butylene succinate) scaffolds and human bone marrow stromal cells induce bone repair in a mouse calvaria model. Journal of tissue engineering and regenerative medicine. Jan. 2012;6(1):… [cited by applicant]
De Geyter et al., Non-thermal plasma surface modification of biodegradable polymers. Biomedical science, engineering and technology. Jan. 20, 2012:225-46. [cited by applicant]
Gigli et al., Poly (butylene succinate)-based polyesters for biomedical applications: A review. European Polymer Journal. Feb. 1, 2016;75:431-60. [cited by applicant]
Jacquel et al., Synthesis and properties of poly (butylene succinate): Efficiency of different transesterification catalysts. Journal of Polymer Science Part A: Polymer Chemistry. Dec. 15, 2011;49(24):5301-12. [cited by applicant]
Ji et al., Morphology, rheology, crystallization behavior, and mechanical properties of poly(lactic acid)/poly(butylene succinate)/dicumyl peroxide reactive blends. J App Polym Sci. Sep. 9, 2013;131(3):39580. doi: /10.1… [cited by applicant]
Kun, et al., Biocompatibility of a novel poly (butyl succinate) and polylactic acid blend. Asaio Journal. May 1, 2012;58(3):262-7. [cited by applicant]
Li et al., In vitro evaluation of biodegradable poly (butylene succinate) as a novel biomaterial. Macromolecular bioscience. May 23, 2005;5(5):433-40. [cited by applicant]
Manavitehrani et al., Biomedical applications of biodegradable polyesters. Polymers. Jan. 2016;8(1):20. [cited by applicant]
Ojansivu et al., Knitted 3D scaffolds of polybutylene succinate support human mesenchymal stem cell growth and osteogenesis. Stem cells international. Article ID 5928935. May 7, 2018;11 pages. [cited by applicant]
Ribeiro et al., Evaluation of novel 3D architectures based on knitting technologies for engineering biological tissues. International Conference on Medical Textiles and Healthcare Products, MedTex13, Raleigh, NC, USA. M… [cited by applicant]
Vandesteene et al., Synthesis of branched poly (butylene succinate): Structure properties relationship. Chinese Journal of Polymer Science. Jul. 1, 2016;34(7):873-88. [cited by applicant]
Wang, et al., Biocompatibility and bioactivity of plasma-treated biodegradable poly (butylene succinate), Acta Biomaterialia, 5(1): 279-287 (2009). [cited by applicant]
Xu et al., Poly (butylene succinate) and its copolymers: Research, development and industrialization. Biotechnology journal. Nov. 2010;5(11):1149-63. [cited by applicant]